Anteris Technologies Global Corp. has entered into a significant agreement with Switchback Medical, LLC, under a First Amended and Restated Master Services Agreement (A&R MSA) signed on July 28, 2025. This agreement appoints Switchback to deliver development and manufacturing services, including engineering and testing, for Anteris Technologies. The contract outlines that Switchback will perform these services in accordance with specified purchase orders and quality standards. A notable element of this agreement is the limited, exclusive license granted to Switchback to use certain Anteris Technologies' intellectual property, strictly for manufacturing purposes during the agreement's term. The A&R MSA is set to expire on March 31, 2028, with provisions for automatic one-year renewals unless either party opts out 180 days before the renewal date. This strategic partnership is expected to enhance Anteris Technologies' operational capabilities in product development and manufacturing.